6-SUBSTITUEREDE 2,3,4,5-TETRAHYDRO-1H-BENZO [D]AZEPINER SOM 5-HT2C-RECEPTORAGONISTER
The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT 2C receptor agonists for the treatment of 5-HT 2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: where: R 6 is -S-L-R 15 and other subst...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | dan |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GALKA, CHRISTOPHER, STANLEY BRINER, KARIN RODRIGUEZ, MICHAEL, JOHN COHEN, MICHAEL, PHILIP SINGH, AJAY ALLEN, JOHN, GORDON HELLMAN, SARAH, LYNNE TIDWELL, MICHAEL, WADE LEE, WAI-MAN SIEDEM, CHRISTOPHER, STEPHEN WILLIAMS, ANDREW CAERWYN ROTHHAAR, ROGER, RYAN REINHARD, MATTHEW, ROBERT ZHANG, DEYI MARTINEZ-GRAU, MARIA ANGELES VICTOR, FRANTZ |
| description | The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT 2C receptor agonists for the treatment of 5-HT 2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety:
where:
R 6 is -S-L-R 15
and other substituents are as defined in the specification. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK1720836TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK1720836TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK1720836TT33</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAuDqL-Q9x7YBNbXdvkNEFsyuU6WJFSJE6ihfr_uPgBTm9584QLCG0V2HGLhAaFTFW6TXNgZCrtxZCHzEKFdefF1dzKDhtXI4ngzyIHy1IDocaGPZVHX7vASMtk9hieU1z9XCTrA7K2EMd3H6dxuMdX_PTmlO3kZq8KZqX-OV__JjA7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>6-SUBSTITUEREDE 2,3,4,5-TETRAHYDRO-1H-BENZO [D]AZEPINER SOM 5-HT2C-RECEPTORAGONISTER</title><source>esp@cenet</source><creator>GALKA, CHRISTOPHER, STANLEY ; BRINER, KARIN ; RODRIGUEZ, MICHAEL, JOHN ; COHEN, MICHAEL, PHILIP ; SINGH, AJAY ; ALLEN, JOHN, GORDON ; HELLMAN, SARAH, LYNNE ; TIDWELL, MICHAEL, WADE ; LEE, WAI-MAN ; SIEDEM, CHRISTOPHER, STEPHEN ; WILLIAMS, ANDREW CAERWYN ; ROTHHAAR, ROGER, RYAN ; REINHARD, MATTHEW, ROBERT ; ZHANG, DEYI ; MARTINEZ-GRAU, MARIA ANGELES ; VICTOR, FRANTZ</creator><creatorcontrib>GALKA, CHRISTOPHER, STANLEY ; BRINER, KARIN ; RODRIGUEZ, MICHAEL, JOHN ; COHEN, MICHAEL, PHILIP ; SINGH, AJAY ; ALLEN, JOHN, GORDON ; HELLMAN, SARAH, LYNNE ; TIDWELL, MICHAEL, WADE ; LEE, WAI-MAN ; SIEDEM, CHRISTOPHER, STEPHEN ; WILLIAMS, ANDREW CAERWYN ; ROTHHAAR, ROGER, RYAN ; REINHARD, MATTHEW, ROBERT ; ZHANG, DEYI ; MARTINEZ-GRAU, MARIA ANGELES ; VICTOR, FRANTZ</creatorcontrib><description>The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT 2C receptor agonists for the treatment of 5-HT 2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety:
where:
R 6 is -S-L-R 15
and other substituents are as defined in the specification.</description><language>dan</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140505&DB=EPODOC&CC=DK&NR=1720836T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140505&DB=EPODOC&CC=DK&NR=1720836T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GALKA, CHRISTOPHER, STANLEY</creatorcontrib><creatorcontrib>BRINER, KARIN</creatorcontrib><creatorcontrib>RODRIGUEZ, MICHAEL, JOHN</creatorcontrib><creatorcontrib>COHEN, MICHAEL, PHILIP</creatorcontrib><creatorcontrib>SINGH, AJAY</creatorcontrib><creatorcontrib>ALLEN, JOHN, GORDON</creatorcontrib><creatorcontrib>HELLMAN, SARAH, LYNNE</creatorcontrib><creatorcontrib>TIDWELL, MICHAEL, WADE</creatorcontrib><creatorcontrib>LEE, WAI-MAN</creatorcontrib><creatorcontrib>SIEDEM, CHRISTOPHER, STEPHEN</creatorcontrib><creatorcontrib>WILLIAMS, ANDREW CAERWYN</creatorcontrib><creatorcontrib>ROTHHAAR, ROGER, RYAN</creatorcontrib><creatorcontrib>REINHARD, MATTHEW, ROBERT</creatorcontrib><creatorcontrib>ZHANG, DEYI</creatorcontrib><creatorcontrib>MARTINEZ-GRAU, MARIA ANGELES</creatorcontrib><creatorcontrib>VICTOR, FRANTZ</creatorcontrib><title>6-SUBSTITUEREDE 2,3,4,5-TETRAHYDRO-1H-BENZO [D]AZEPINER SOM 5-HT2C-RECEPTORAGONISTER</title><description>The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT 2C receptor agonists for the treatment of 5-HT 2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety:
where:
R 6 is -S-L-R 15
and other substituents are as defined in the specification.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAuDqL-Q9x7YBNbXdvkNEFsyuU6WJFSJE6ihfr_uPgBTm9584QLCG0V2HGLhAaFTFW6TXNgZCrtxZCHzEKFdefF1dzKDhtXI4ngzyIHy1IDocaGPZVHX7vASMtk9hieU1z9XCTrA7K2EMd3H6dxuMdX_PTmlO3kZq8KZqX-OV__JjA7</recordid><startdate>20140505</startdate><enddate>20140505</enddate><creator>GALKA, CHRISTOPHER, STANLEY</creator><creator>BRINER, KARIN</creator><creator>RODRIGUEZ, MICHAEL, JOHN</creator><creator>COHEN, MICHAEL, PHILIP</creator><creator>SINGH, AJAY</creator><creator>ALLEN, JOHN, GORDON</creator><creator>HELLMAN, SARAH, LYNNE</creator><creator>TIDWELL, MICHAEL, WADE</creator><creator>LEE, WAI-MAN</creator><creator>SIEDEM, CHRISTOPHER, STEPHEN</creator><creator>WILLIAMS, ANDREW CAERWYN</creator><creator>ROTHHAAR, ROGER, RYAN</creator><creator>REINHARD, MATTHEW, ROBERT</creator><creator>ZHANG, DEYI</creator><creator>MARTINEZ-GRAU, MARIA ANGELES</creator><creator>VICTOR, FRANTZ</creator><scope>EVB</scope></search><sort><creationdate>20140505</creationdate><title>6-SUBSTITUEREDE 2,3,4,5-TETRAHYDRO-1H-BENZO [D]AZEPINER SOM 5-HT2C-RECEPTORAGONISTER</title><author>GALKA, CHRISTOPHER, STANLEY ; BRINER, KARIN ; RODRIGUEZ, MICHAEL, JOHN ; COHEN, MICHAEL, PHILIP ; SINGH, AJAY ; ALLEN, JOHN, GORDON ; HELLMAN, SARAH, LYNNE ; TIDWELL, MICHAEL, WADE ; LEE, WAI-MAN ; SIEDEM, CHRISTOPHER, STEPHEN ; WILLIAMS, ANDREW CAERWYN ; ROTHHAAR, ROGER, RYAN ; REINHARD, MATTHEW, ROBERT ; ZHANG, DEYI ; MARTINEZ-GRAU, MARIA ANGELES ; VICTOR, FRANTZ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK1720836TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GALKA, CHRISTOPHER, STANLEY</creatorcontrib><creatorcontrib>BRINER, KARIN</creatorcontrib><creatorcontrib>RODRIGUEZ, MICHAEL, JOHN</creatorcontrib><creatorcontrib>COHEN, MICHAEL, PHILIP</creatorcontrib><creatorcontrib>SINGH, AJAY</creatorcontrib><creatorcontrib>ALLEN, JOHN, GORDON</creatorcontrib><creatorcontrib>HELLMAN, SARAH, LYNNE</creatorcontrib><creatorcontrib>TIDWELL, MICHAEL, WADE</creatorcontrib><creatorcontrib>LEE, WAI-MAN</creatorcontrib><creatorcontrib>SIEDEM, CHRISTOPHER, STEPHEN</creatorcontrib><creatorcontrib>WILLIAMS, ANDREW CAERWYN</creatorcontrib><creatorcontrib>ROTHHAAR, ROGER, RYAN</creatorcontrib><creatorcontrib>REINHARD, MATTHEW, ROBERT</creatorcontrib><creatorcontrib>ZHANG, DEYI</creatorcontrib><creatorcontrib>MARTINEZ-GRAU, MARIA ANGELES</creatorcontrib><creatorcontrib>VICTOR, FRANTZ</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GALKA, CHRISTOPHER, STANLEY</au><au>BRINER, KARIN</au><au>RODRIGUEZ, MICHAEL, JOHN</au><au>COHEN, MICHAEL, PHILIP</au><au>SINGH, AJAY</au><au>ALLEN, JOHN, GORDON</au><au>HELLMAN, SARAH, LYNNE</au><au>TIDWELL, MICHAEL, WADE</au><au>LEE, WAI-MAN</au><au>SIEDEM, CHRISTOPHER, STEPHEN</au><au>WILLIAMS, ANDREW CAERWYN</au><au>ROTHHAAR, ROGER, RYAN</au><au>REINHARD, MATTHEW, ROBERT</au><au>ZHANG, DEYI</au><au>MARTINEZ-GRAU, MARIA ANGELES</au><au>VICTOR, FRANTZ</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>6-SUBSTITUEREDE 2,3,4,5-TETRAHYDRO-1H-BENZO [D]AZEPINER SOM 5-HT2C-RECEPTORAGONISTER</title><date>2014-05-05</date><risdate>2014</risdate><abstract>The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT 2C receptor agonists for the treatment of 5-HT 2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety:
where:
R 6 is -S-L-R 15
and other substituents are as defined in the specification.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | dan |
| recordid | cdi_epo_espacenet_DK1720836TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 6-SUBSTITUEREDE 2,3,4,5-TETRAHYDRO-1H-BENZO [D]AZEPINER SOM 5-HT2C-RECEPTORAGONISTER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T01%3A37%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GALKA,%20CHRISTOPHER,%20STANLEY&rft.date=2014-05-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK1720836TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |